Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Egle

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
BMC Cancer|December 24, 2015
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck CancerFlorian Huemer, Thomas Melchardt, Wolfgang Tränkenschuh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPIThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Leukemia & Lymphoma|May 7, 2014
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeuticsThomas Melchardt, Lukas Weiss, Clemens Hufnagl, et al.
Stem Cells (Dayton, Ohio)|February 4, 2021
Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemiaFranziska von Heydebrand, Maximilian Fuchs, Meik Kunz, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Oncotarget|July 8, 2016
CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cellsNadja Zaborsky, Franz Josef Gassner, Daniela Asslaber, et al.
British Journal of Haematology|September 20, 2014
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulinThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
European Journal of Haematology|December 16, 2019
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomasSandro M Wagner, Thomas Melchardt, Alexander Egle, et al.
Leukemia|July 31, 2020
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemiaFranz J Gassner, Nadja Zaborsky, Ilana Buchumenski, et al.
Oncoimmunology|January 4, 2018
TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemiaKemal Catakovic, Franz Josef Gassner, Christoph Ratswohl, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
BMC Cancer|December 24, 2015
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck CancerFlorian Huemer, Thomas Melchardt, Wolfgang Tränkenschuh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPIThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Leukemia & Lymphoma|May 7, 2014
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeuticsThomas Melchardt, Lukas Weiss, Clemens Hufnagl, et al.
Stem Cells (Dayton, Ohio)|February 4, 2021
Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemiaFranziska von Heydebrand, Maximilian Fuchs, Meik Kunz, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Oncotarget|July 8, 2016
CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cellsNadja Zaborsky, Franz Josef Gassner, Daniela Asslaber, et al.
British Journal of Haematology|September 20, 2014
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulinThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
European Journal of Haematology|December 16, 2019
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomasSandro M Wagner, Thomas Melchardt, Alexander Egle, et al.
Leukemia|July 31, 2020
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemiaFranz J Gassner, Nadja Zaborsky, Ilana Buchumenski, et al.
Oncoimmunology|January 4, 2018
TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemiaKemal Catakovic, Franz Josef Gassner, Christoph Ratswohl, et al.
Pageof 11